Skip to end of metadata
Go to start of metadata

 Show Changes

1a. Project Name

Skin and Wound Assessment PSS

1c. Is Your Project an Investigative Project (aka PSS-Lite)?


1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?


2a. Primary/Sponsor WG

Patient Administration

2b. Co-Sponsor WG

Clinical Genomics

2c. Co-Sponsor Level of Involvement

Request formal content review prior to ballot

2b. Co-Sponsor WG 2


2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2c. Co-Sponsor 2 Update Periods

Weekly as appropriate

2b. Co-Sponsor WG 3

Clinical Information Modeling Initiative

2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2d. Project Facilitator

Susan Matney

2e. Other Interested Parties (and roles)

Michael Brody, DPM. CEO Registry Clearinghouse

2f. Modeling Facilitator

Nathan Davis

2h. Vocabulary Facilitator

Susan Matney

2i. Domain Expert Representative

National Pressure Ulcer Advisory Panel

2m. Implementers

Podiatry group
Tissue Analytics
Intermountain Heatlhcare

3a. Project Scope

To develop a skin and wound assessment model and FHIR profiles which can be used to document, track and trend wound care across settings.

3b. Project Need

Wound care is a clinical domain of high interest because iatrogenic skin and tissue breakdowns (e.g., pressure ulcers) and the mitigation of risk for skin breakdown are recognized as indicators of quality. The National Quality Forum endorsed pressure ulcers as a nursing sensitive outcome measure, and the Centers for Medicare and Medicaid Services (CMS) view hospital acquired pressure ulcers as a preventable hospital acquired condition for which hospitals no longer receive added reimbursement.

Wounds are also cared for across settings. Wounds are documented in three different apps within Intermountain Healthcare, one of which is Tissue Analytics - therefore, Intermountain would like to implement the FHIR profiles within their enterprise.

3c. Security Risk


3d. External Drivers

Veteran's Administration, National Pressure Ulcer Advisory Panel, Podiatrists

3e. Objectives/Deliverables and Target Dates

1. Develop the logical model (complete)
2. Curate the needed terminology content with LOINC and SNOMED CT (complete).
3. Develop the FHIR profiles (R3) (complete)
4. Test the FHIR profiles during a connectathon (Done in Montreal)
5. Convert to R4 FHIR profiles
6. Enhance FHIR profile for implementers, including expanding body locations (in progress, target is 9/30/2019).
7. Develop the IG
8. Collaborate with implementers FHIR enable their applications (no set date yet).
9. Pilot test
10. Ballot in January 2020

3f. Common Names / Keywords / Aliases:

Wound Assessment

3i. HL7-Managed Project Document Repository URL:

3j. Backwards Compatibility


3l. Using Current V3 Data Types?


3m. External Vocabularies


3n. List of Vocabularies


4a. Products

FHIR Implementation Guide, FHIR Profiles

5a. Project Intent

Create new standard

5b. Project Ballot Type

STU to Normative

5d. Joint Copyright


6a. External Project Collaboration

National Pressure Ulcer Advisory Panel
Wound care nurses at the Veteran's administration as subject matter experts.

6c. Content externally developed?


6d. List Developers of Externally Developed Content

Nursing Knowledge Big Data Science Initiative
Solor content developers (Keith Campbell, Susan Matney, et al.)
Intermountain Healthcare

6e. Is this a hosted (externally funded) project?


6f. Stakeholders

Quality Reporting Agencies, Regulatory Agency, Standards Development Organizations (SDOs), Payors

6g. Vendors


6h. Providers

Emergency Services, Healthcare Institutions (hospitals, long term care, home care, mental health)

6i. Realm


7a. Management Group(s) to Review PSS


7b. Sponsoring WG Approval Date

May 23, 2019

7c. Co-Sponsor Approval Date

May 23, 2019

7c. Co-Sponsor 2 Approval Date

May 28, 2019

7c. Co-Sponsor 3 Approval Date

May 23, 2019